Showing 12 out of 2273 items
- CATIE NewsLong-acting injectable PrEP will hopefully be approved in the spring of 2024 in Canada. Long-acting PrEP has been approved in the U.S. – learning from their experience may be useful. Researchers in…
- CATIE NewsRisk mitigation guidance in B.C. allows opioid and stimulant prescriptions for people at risk of overdose. A study examined the effect of these prescriptions on deaths and hospital visits.…
- Reinfection rates continue to be low among people with HIV who have recovered from hepatitis C virusCATIE NewsCoinfection with hepatitis C virus (HCV) can occur among some people with HIV. Researchers in six countries monitored 6,144 people with HIV who had recovered from HCV. Combined rates of reinfection…
Government of Canada's sexually transmitted and blood-borne infections (STBBI) action plan 2024-2030The Government of Canada's renewed 2024-2030 STBBI Action Plan builds on our progress to date and reaffirms our commitment to achieve the World Health Organization (WHO) 2030 global STBBI…- CATIE NewsSwiss researchers analysed data from 1,630 people with HIV who died between 2005 and 2022. While deaths from HIV fell, deaths from cancer and heart disease became more prominent. More research on the…
-
- Post-exposure doxycycline helps reduce the risk for some sexually transmitted infections
- Large study confirms near-normal life expectancy for many people on HIV treatment
- Australian researchers find treatment as prevention (TasP) works in men who have sex with men
- Safety and effectiveness of dolutegravir + 3TC in people with HIV aged 65 and older